A new research report indicates that current NHS protocols for screening younger women for breast cancer are insufficient. Investigations led by Cambridge University and the Institute of Cancer Research suggest that existing guidelines, which rely heavily on family medical history, fail to detect up to 95% of women under 50 who are at an elevated risk of developing the disease.
The study, published in the British Journal of Cancer, contrasts current Nice criteria with a tool known as Boadicea. While the NHS guidelines currently identify only 4.4% of women in this age bracket who later develop cancer, the Boadicea tool—which evaluates lifestyle, reproductive history, and genetic factors—could identify over a third of these cases. Researchers noted that nearly three-quarters of women under 50 who develop breast cancer lack a family history of the condition, rendering the current primary metric ineffective.
Dr. Juliet Usher-Smith, the lead researcher, suggested that while these findings warrant a formal review of NHS procedures, the practical impact on healthcare workloads and the potential for increased patient anxiety must be managed carefully. Cancer Research UK echoed this, emphasizing the need for equitable access to any future screening updates. For now, Nice has indicated that while they find the study promising, current evidence is not sufficient to justify an immediate change to national guidelines.
